Aster DM Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Aster DM Healthcare CEO'su Alisha Moopen, Jan2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.043% doğrudan sahiptir ve bu hisselerin değeri ₹ 93.31M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.8 yıl ve 4.4 yıldır.

Anahtar bilgiler

Alisha Moopen

İcra Kurulu Başkanı

₹3.0m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	1.8yrs
Yönetim Kurulu ortalama görev süresi	4.4yrs

Son yönetim güncellemeleri

Recent updates

Aster DM Healthcare's (NSE:ASTERDM) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Oct 31

Here's What's Concerning About Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Oct 14

Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing

Jul 20

Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal

Jun 23

Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt

May 30

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Apr 14

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Mar 27

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 12

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Feb 07

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Jan 19

Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?

Apr 03

Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?

Mar 02

Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?

Dec 17

CEO

Alisha Moopen (42 yo)

less than a year

Görev süresi

₹3,000,000

Tazminat

Ms. Alisha Moopen had been Deputy Managing Director of Aster DM Healthcare Limited since August 7, 2019 and serves as its Group Chief Executive Officer since 2024. Ms. Moopen has been the Director of Aster...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Mandayapurath Moopen	Founder & Chairman	16.8yrs	₹6.00m	0.40% ₹ 870.5m
Alisha Moopen	MD, Group CEO & Director	less than a year	₹3.00m	0.043% ₹ 93.3m
Sunil Kumar M. R.	Chief Financial Officer	less than a year	₹17.50m	Veri yok
S. Kumar	Group Chief Operating Officer	less than a year	₹12.90m	Veri yok
Hemish Purushottam	Company Secretary & Compliance Officer	3yrs	₹4.00m	Veri yok
Thadathil Wilson	Group Head of Governance & Corporate Affairs & Executive Director	9yrs	Veri yok	0.52% ₹ 1.1b
Harsha Rajaram	Chief Executive Officer of Aster Digital Health	no data	₹12.30m	Veri yok
Veneeth Purushotaman	Group Chief Information Officer	6.8yrs	Veri yok	Veri yok
Rahul Kadavakolu	Group Chief Marketing Officer	1.8yrs	Veri yok	Veri yok
Malathi Arshanapalai	Group Chief Medical & Quality Officer	9.8yrs	Veri yok	Veri yok
Srinath Metla	Country Head of Sales & Marketing	no data	Veri yok	Veri yok
Amitabh Johri	Chief Financial Officer of Gulf Co-operation Council	less than a year	Veri yok	Veri yok

1.8yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: ASTERDM 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Mandayapurath Moopen	Founder & Chairman	16.8yrs	₹6.00m	0.40% ₹ 870.5m
Alisha Moopen	MD, Group CEO & Director	11.2yrs	₹3.00m	0.043% ₹ 93.3m
Thadathil Wilson	Group Head of Governance & Corporate Affairs & Executive Director	15.6yrs	Veri yok	0.52% ₹ 1.1b
Chenayappillil George	Non-Executive Independent Director	4.6yrs	₹2.30m	Veri yok
James Mathew	Non-Executive Independent Director	4.4yrs	₹3.00m	Veri yok
Maniedath Nambiar	Non-Executive Independent Director	less than a year	₹1.40m	Veri yok
Anoop Moopen	Non-Executive Non-Independent Director	less than a year	Veri yok	0.30% ₹ 646.3m
Shamsudheen Bin Mohideen Mammu Haji	Non-Executive Director	9.2yrs	Veri yok	1.14% ₹ 2.4b
Emmanuel Gootam	Non-Executive Independent Director	2yrs	₹2.60m	Veri yok
Purana Housdurgam Deepti	Non-Executive Independent Director	1.7yrs	₹2.20m	Veri yok
Zeba Moopen	Non-Executive Non- Independent Director	less than a year	Veri yok	Veri yok

4.4yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ASTERDM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.4 yıldır).

Aster DM Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Aster DM Healthcare Appoints Mohamed Alshamari as CEO of Aster Hospitals and Clinics in Saudi Arabia

Aster DM Healthcare Limited Announces Executive Changes

High number of new directors

Aster DM Healthcare Limited Approves Board Appointments

Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024

Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel

Recent updates

Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap

Aster DM Healthcare's (NSE:ASTERDM) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Price target increased by 9.1% to ₹463

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Aster DM Healthcare Limited to Report Q2, 2025 Results on Oct 23, 2024

Here's What's Concerning About Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Consensus EPS estimates fall by 13%

Aster DM Healthcare Appoints Mohamed Alshamari as CEO of Aster Hospitals and Clinics in Saudi Arabia

Aster DM Healthcare and Quality CARE Reportedly in Final Stages of Negotiations and Expects Deal to be Sign by the End of September 2024

Aster DM Healthcare Limited Announces Executive Changes

High number of new directors

Aster DM Healthcare Limited Approves Board Appointments

Upcoming dividend of ₹2.00 per share

Blackstone Reportedly in Talks with the Promoters of Aster DM Healthcare to Merge Quality Care India with Aster

First quarter 2025 earnings released: EPS: ₹1.49 (vs ₹0.10 in 1Q 2024)

Aster DM Healthcare Limited to Report Q1, 2025 Results on Jul 31, 2024

Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing

Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal

Olympus Capital Asia Investments to Sell Up to 10% Stake in Aster DM Healthcare through Block Deals

Consensus EPS estimates fall by 93%, revenue upgraded

Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024

Price target decreased by 7.3% to ₹453

Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24

Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt

Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24

Full year 2024 earnings released: EPS: ₹2.46 (vs ₹8.54 in FY 2023)

Aster DM Healthcare Limited to Report Q4, 2024 Results on May 28, 2024

Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 23%

Aster DM Healthcare Limited Declares Special Dividend

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Aster DM Healthcare Limited Declares Special Dividend

Investor sentiment improves as stock rises 19%

Aster DM Healthcare Limited Announces Board Changes

Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Price target increased by 9.3% to ₹459

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New major risk - Financial position

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Now 20% undervalued

KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare

Aster DM Healthcare to Fuel India Expansion Through Buyouts

Now 20% undervalued

New minor risk - Share price stability

Consensus EPS estimates fall by 16%

Price target increased by 18% to ₹397

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023)

Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion

New major risk - Financial position

Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director

Full year 2023 earnings: EPS misses analyst expectations

Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023

Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023

Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business

Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 15%, revenue upgraded

Price target increased by 7.6% to ₹291

Aster Eye $300 million India Stake Sale

Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022)

Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director

Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023

Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022)